(Q43993057)

28 November 2017

title

Contributions of basal and prandial hyperglycemia to total hyperglycemia in older and younger adults with type 2 diabetes mellitus (English)

1 reference

28 November 2017

1 reference

1 reference

Medha N Munshi

1

1 reference

28 November 2017

Naushira Pandya

2

1 reference

28 November 2017

Guillermo E Umpierrez

3

1 reference

28 November 2017

Andres DiGenio

4

1 reference

28 November 2017

Rong Zhou

5

1 reference

28 November 2017

Matthew C Riddle

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

21 March 2013

1 reference

Journal of the American Geriatrics Society

28 November 2017

published in

1 reference

28 November 2017

volume

61

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

535-541

1 reference

Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050.

28 November 2017

cites work

1 reference

Standards of medical care in diabetes--2011.

21 January 2018

1 reference

Glucose control in the older patient: from intensive, to effective and safe

21 January 2018

1 reference

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

21 January 2018

1 reference

Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes

21 January 2018

1 reference

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

21 January 2018

1 reference

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

21 January 2018

1 reference

Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes: an assessment of treatment flexibility

21 January 2018

1 reference

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

21 January 2018

1 reference

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes

21 January 2018

1 reference

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies

21 January 2018

1 reference

Follow-up report on the diagnosis of diabetes mellitus

21 January 2018

1 reference

Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.

21 January 2018

1 reference

Frequent hypoglycemia among elderly patients with poor glycemic control

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGS.12167

1 reference

28 November 2017

1 reference